Page results
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
This is information for women who have been given a diagnosis of adenomyosis.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Bones marrow harvest patient information page.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
File results
-
FOI/2022/0774 - Pre-pregnancy counselling clinics with consultant-led maternity units for women with medical problems
-
FOI/2022/0772 - Treatments for rare diseases
-
FOI/2022/0770 - Parking operations, impact, and parking charge notices issued
-
FOI/2022/0768 - Patients treated for Haemophila A
-
FOI/2022/0764 - Patients treated for drinks spiked/ spiked by needle injection
-
FOI/2022/0763 - Treatment of dermatological conditions
-
FOI/2022/0739 - Treatment of HR+ adjuvant breast cancer
-
FOI/2022/0741 - Number of women in the maternity service identified as needing an interpreter
-
FOI2017263 Self-administration of medicines policies and carers policies
-
FOI/2022/0742 - Allegations of sexual misconduct in NHS Trusts